Alzheimer's disease Trials in Plymouth, United Kingdom
Conditions / Alzheimer's disease / Plymouth, United Kingdom
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04828122 | Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech | COMPLETED | — |
| NCT03446001 | Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment | COMPLETED | PHASE3 |
| NCT04795466 | Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease | TERMINATED | PHASE2 |
| NCT03823404 | GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease | COMPLETED | PHASE2/PHASE3 |
| NCT02240693 | Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo | COMPLETED | PHASE2 |
| NCT02337907 | BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. | COMPLETED | PHASE2 |
| NCT05318976 | A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation | COMPLETED | PHASE2 |
| NCT04851496 | Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension | UNKNOWN | — |
| NCT04592874 | A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease | COMPLETED | PHASE2 |
| NCT05508789 | A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) | RECRUITING | PHASE3 |